跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 6,476 条关于
“Breakthrough Victoria”
全部
6,476
临床试验
274
药物
39
机构
30
资讯
6,133
Biotech
Approved
Haemagglutinin-strain B (Victoria-like)
(Afluria Tetra, FluLaval Tetra, Fluzone High-Dose Quadrivalent, Fluzone Quadrivalent, Influvac Tetra)
Biotech
Approved
Influenza B virus Victoria lineage haemagglutinin, recombinant
sodium channel blockers (Neurosciences Victoria/Howard Florey Institute)
Synthetic Tumor-Specific Breakpoint Peptide Vaccine(BreakThrough Therapeutics)
Biotech
Approved
Influenza virus type B (Victoria)
(FluMist Quadrivalent)
Biotech
Approved
Influenza A virus A/Victoria/361/2011 (H3N2) recombinant hemagglutinin antigen
DMXD-011
Biotech
Approved
Influenza A virus A/Victoria/361/2011 (H3N2) live (attenuated) antigen
Biotech
Approved
Influenza A virus A/Victoria/4897/2022 IVR-238 (H1N1) Antigen (propiolactone inactivated)
(Afluria Quadrivalent)
Biotech
Approved
Influenza A Virus A/Victoria/4897/2022 IVR-238 (H1N1) antigen (formaldehyde inactivated)
(Fluad Quadrivalent, Fluarix Quadrivalent, Fluzone High-Dose Quadrivalent, Fluzone Quadrivalent)
第 1 页,共 4 页
上一页
下一页